Jasper Historical Financial Ratios

JSPR Stock  USD 5.58  0.35  5.90%   
Jasper Therapeutics is lately reporting on over 97 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as PTB Ratio of 5.3 K or Days Sales Outstanding of 0.0 will help investors to properly organize and evaluate Jasper Therapeutics financial condition quickly.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Jasper Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
To learn how to invest in Jasper Stock, please use our How to Invest in Jasper Therapeutics guide.

About Jasper Financial Ratios Analysis

Jasper TherapeuticsFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Jasper Therapeutics investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Jasper financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Jasper Therapeutics history.

Jasper Therapeutics Financial Ratios Chart

At this time, Jasper Therapeutics' Price Book Value Ratio is relatively stable compared to the past year. As of 03/03/2025, Price Earnings To Growth Ratio is likely to grow to 0.18, while Operating Cash Flow Per Share is likely to drop (0).
Add Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
Inventory TurnoverNet Income Per Share
Days Of Inventory On HandPayables Turnover
Sales General And Administrative To RevenueAverage Inventory
Research And Ddevelopement To RevenueCapex To Revenue
Cash Per SharePocfratio
Interest CoveragePayout Ratio
Capex To Operating Cash FlowPfcf Ratio
Days Payables OutstandingNet Current Asset Value
Income QualityRoe
Tangible Asset ValueEv To Operating Cash Flow
Pe RatioReturn On Tangible Assets
Ev To Free Cash FlowEarnings Yield
Intangibles To Total AssetsNet Debt To E B I T D A
Current RatioTangible Book Value Per Share
Receivables TurnoverGraham Number
Shareholders Equity Per ShareDebt To Equity
Capex Per ShareGraham Net Net
Average ReceivablesRevenue Per Share
Interest Debt Per ShareDebt To Assets
Enterprise Value Over E B I T D ARoic
Short Term Coverage RatiosPrice Earnings Ratio
Operating CyclePrice Book Value Ratio
Price Earnings To Growth RatioDays Of Payables Outstanding
Dividend Payout RatioPrice To Operating Cash Flows Ratio
Price To Free Cash Flows RatioPretax Profit Margin
Ebt Per EbitOperating Profit Margin
Effective Tax RateCompany Equity Multiplier
Long Term Debt To CapitalizationTotal Debt To Capitalization
Return On Capital EmployedDebt Equity Ratio
Ebit Per RevenueQuick Ratio
Dividend Paid And Capex Coverage RatioNet Income Per E B T
Cash RatioCash Conversion Cycle
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity

Payables Turnover

A liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable.

Income Quality

An assessment of the sustainability of a company's earnings over time, considering factors like revenue source diversification and cost structure.
Most ratios from Jasper Therapeutics' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Jasper Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Jasper Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
To learn how to invest in Jasper Stock, please use our How to Invest in Jasper Therapeutics guide.At this time, Jasper Therapeutics' Price Book Value Ratio is relatively stable compared to the past year. As of 03/03/2025, Price Earnings To Growth Ratio is likely to grow to 0.18, while Operating Cash Flow Per Share is likely to drop (0).
 2022 2023 2024 2025 (projected)
Current Ratio5.917.194.988.77
Net Debt To EBITDA0.911.290.920.87

Jasper Therapeutics fundamentals Correlations

0.460.470.68-0.661.00.68-0.610.59-0.570.25-0.71-1.00.65-1.0-0.560.27-0.56-1.0-0.04-0.48-1.00.20.43-0.49-0.48
0.46-0.060.91-0.740.460.91-0.970.97-0.980.72-0.72-0.460.74-0.46-0.980.92-0.62-0.46-0.65-0.38-0.460.670.98-0.85-0.66
0.47-0.06-0.010.130.47-0.010.03-0.070.06-0.650.08-0.47-0.11-0.470.09-0.37-0.03-0.47-0.25-0.11-0.470.480.040.060.15
0.680.91-0.01-0.940.681.0-0.980.99-0.980.75-0.94-0.680.94-0.68-0.980.8-0.74-0.68-0.32-0.52-0.680.430.83-0.85-0.76
-0.66-0.740.13-0.94-0.66-0.950.87-0.890.86-0.791.00.66-1.00.660.87-0.670.730.66-0.010.540.66-0.13-0.60.750.76
1.00.460.470.68-0.660.68-0.610.59-0.570.25-0.71-1.00.65-1.0-0.560.27-0.56-1.0-0.04-0.48-1.00.20.43-0.49-0.48
0.680.91-0.011.0-0.950.68-0.980.98-0.970.76-0.94-0.680.95-0.68-0.970.8-0.74-0.68-0.3-0.52-0.680.420.82-0.84-0.76
-0.61-0.970.03-0.980.87-0.61-0.98-1.01.0-0.760.860.61-0.870.611.0-0.880.70.610.480.460.61-0.55-0.920.870.73
0.590.97-0.070.99-0.890.590.98-1.0-1.00.79-0.88-0.580.89-0.58-1.00.88-0.7-0.59-0.44-0.47-0.590.510.9-0.87-0.74
-0.57-0.980.06-0.980.86-0.57-0.971.0-1.0-0.770.850.57-0.860.571.0-0.890.690.570.490.450.57-0.56-0.930.870.73
0.250.72-0.650.75-0.790.250.76-0.760.79-0.77-0.76-0.250.78-0.25-0.790.85-0.53-0.25-0.07-0.32-0.25-0.010.59-0.67-0.67
-0.71-0.720.08-0.941.0-0.71-0.940.86-0.880.85-0.760.71-1.00.710.85-0.640.730.71-0.030.550.71-0.12-0.590.740.76
-1.0-0.46-0.47-0.680.66-1.0-0.680.61-0.580.57-0.250.71-0.651.00.56-0.280.561.00.040.481.0-0.2-0.440.490.49
0.650.74-0.110.94-1.00.650.95-0.870.89-0.860.78-1.0-0.65-0.65-0.870.66-0.73-0.650.01-0.54-0.650.140.6-0.75-0.76
-1.0-0.46-0.47-0.680.66-1.0-0.680.61-0.580.57-0.250.711.0-0.650.56-0.280.561.00.040.481.0-0.2-0.440.490.49
-0.56-0.980.09-0.980.87-0.56-0.971.0-1.01.0-0.790.850.56-0.870.56-0.90.690.560.470.450.56-0.53-0.920.870.73
0.270.92-0.370.8-0.670.270.8-0.880.88-0.890.85-0.64-0.280.66-0.28-0.9-0.42-0.28-0.54-0.42-0.280.470.88-0.86-0.75
-0.56-0.62-0.03-0.740.73-0.56-0.740.7-0.70.69-0.530.730.56-0.730.560.69-0.420.560.13-0.130.56-0.24-0.540.270.17
-1.0-0.46-0.47-0.680.66-1.0-0.680.61-0.590.57-0.250.711.0-0.651.00.56-0.280.560.040.481.0-0.2-0.440.490.49
-0.04-0.65-0.25-0.32-0.01-0.04-0.30.48-0.440.49-0.07-0.030.040.010.040.47-0.540.130.04-0.010.04-0.93-0.780.430.11
-0.48-0.38-0.11-0.520.54-0.48-0.520.46-0.470.45-0.320.550.48-0.540.480.45-0.42-0.130.48-0.010.48-0.12-0.310.80.88
-1.0-0.46-0.47-0.680.66-1.0-0.680.61-0.590.57-0.250.711.0-0.651.00.56-0.280.561.00.040.48-0.2-0.440.490.49
0.20.670.480.43-0.130.20.42-0.550.51-0.56-0.01-0.12-0.20.14-0.2-0.530.47-0.24-0.2-0.93-0.12-0.20.78-0.48-0.19
0.430.980.040.83-0.60.430.82-0.920.9-0.930.59-0.59-0.440.6-0.44-0.920.88-0.54-0.44-0.78-0.31-0.440.78-0.8-0.57
-0.49-0.850.06-0.850.75-0.49-0.840.87-0.870.87-0.670.740.49-0.750.490.87-0.860.270.490.430.80.49-0.48-0.80.93
-0.48-0.660.15-0.760.76-0.48-0.760.73-0.740.73-0.670.760.49-0.760.490.73-0.750.170.490.110.880.49-0.19-0.570.93
Click cells to compare fundamentals

Jasper Therapeutics Account Relationship Matchups

Jasper Therapeutics fundamentals Accounts

202020212022202320242025 (projected)
Income Quality0.581.11.220.810.880.66
Roe0.9(0.35)(0.67)(0.82)(0.95)(0.9)
Ev To Operating Cash Flow(0.52)(0.23)0.370.0334(5.0K)(4.7K)
Return On Tangible Assets(1.31)(0.25)(0.49)(0.68)(0.78)(0.82)
Ev To Free Cash Flow(0.52)(0.21)0.370.0332(4.9K)(4.7K)
Net Debt To E B I T D A0.572.630.911.290.920.87
Current Ratio5.1610.955.917.194.988.77
Enterprise Value Over E B I T D A(0.3)(0.24)0.440.0267(4.1K)(3.9K)
Roic(1.07)(0.33)(0.76)(0.8)(0.93)(0.97)

Pair Trading with Jasper Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Jasper Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Jasper Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Moving against Jasper Stock

  0.77OPT Opthea Upward RallyPairCorr
  0.74LTRN Lantern PharmaPairCorr
  0.73GANX Gain TherapeuticsPairCorr
  0.69PHGE Biomx IncPairCorr
  0.67CUE Cue BiopharmaPairCorr
The ability to find closely correlated positions to Jasper Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Jasper Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Jasper Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Jasper Therapeutics to buy it.
The correlation of Jasper Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Jasper Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Jasper Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Jasper Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Jasper Stock Analysis

When running Jasper Therapeutics' price analysis, check to measure Jasper Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jasper Therapeutics is operating at the current time. Most of Jasper Therapeutics' value examination focuses on studying past and present price action to predict the probability of Jasper Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jasper Therapeutics' price. Additionally, you may evaluate how the addition of Jasper Therapeutics to your portfolios can decrease your overall portfolio volatility.